Elodie Aubrun
Novartis

Chris Boone
AbbVie

Florence Bourgeois
Harvard-MIT Center for Regulatory Science

Fabricio Carneiro de Oliveira
Brazilian Health Regulatory Agency (ANVISA)

Catherine Cohet
European Medicines Agency

John Concato
Office of Medical Policy, CDER-FDA

Paul Coplan
Johnson & Johnson

Gracy Crane
Roche

Sanket Dhruva
UCSF School of Medicine

Kathleen Donohue
Division of Rare Diseases and Medical Genetics, Office of New Drugs, FDA

Joe Franklin
Verily Life Sciences

Jessica Franklin
Optum Epidemiology